Trial Profile
Phase 2, Randomized, Double Blind, Placebo-Controlled Dose and Schedule Finding Trial to Evaluate the Safety and Efficacy of AMG 531 For Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Advanced Non-Small Cell Lung Cancer Already Receiving Gemcitabine and Platinum.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Nov 2014
Price :
$35
*
At a glance
- Drugs Romiplostim (Primary) ; Carboplatin; Cisplatin; Gemcitabine
- Indications Thrombocytopenia
- Focus Adverse reactions
- Sponsors Amgen
- 18 Nov 2014 New trial record